XML 67 R27.htm IDEA: XBRL DOCUMENT
v3.22.1

FAIR VALUE MEASUREMENTS | 12 Months Ended
--- | ---
Mar. 31, 2022
Fair Value Disclosures [Abstract] |
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, we consider the principal or most advantageous market in which the asset or liability would transact, and if necessary, consider assumptions that market participants would use when pricing the asset or liability. The accounting standard for fair value measurements establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: observable inputs such as quoted prices in active markets (Level 1); inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2); and unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions (Level 3). A financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The financial instruments measured at fair value in the accompanying consolidated balance sheets consist of the following:
| Recurring Fair Value Measurements as of March 31, 2022
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Long term deferred compensation plan asset (1) | 16,512 |  |  | — |  |  | — |  |  | 16,512 |
Long-term derivative instruments (3) | — |  |  | 4,088 |  |  | — |  |  | 4,088 |
Total Assets | $ | 16,512 |  |  | $ | 4,088 |  |  | $ | — |  |  | $ | 20,600 |
Liabilities: |  |  |  |  |  |  |
Current derivative instruments (3) | — |  |  | 4,324 |  |  | — |  |  | 4,324 |
Long-term derivative instruments (3) | — |  |  | 39 |  |  | — |  |  | 39 |
Long term deferred compensation plan liability (1) | 16,512 |  |  | — |  |  | — |  |  | 16,512 |
Total Liabilities | $ | 16,512 |  |  | $ | 4,363 |  |  | $ | — |  |  | $ | 20,875 |
| Recurring Fair Value Measurements as of March 31, 2021
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Long term deferred compensation plan asset (1) | $ | 14,142 |  |  | $ | — |  |  | $ | — |  |  | $ | 14,142 |
Total Assets | $ | 14,142 |  |  | $ | — |  |  | $ | — |  |  | $ | 14,142 |
Liabilities: |  |  |  |  |  |  |
Contingent consideration liability (2) | $ | — |  |  | $ | — |  |  | $ | 1,223 |  |  | $ | 1,223 |
Current derivative instruments (3) | $ | — |  |  | $ | 17,163 |  |  | $ | — |  |  | $ | 17,163 |
Long-term derivative instruments (3) | $ | — |  |  | $ | 20,999 |  |  | $ | — |  |  | $ | 20,999 |
Long term deferred compensation plan liability (1) | $ | 14,142 |  |  | $ | — |  |  | $ | — |  |  | $ | 14,142 |
Total liabilities | $ | 14,142 |  |  | $ | 38,162 |  |  | $ | 1,223 |  |  | $ | 53,527 |
(1) Investments in this category consist of primarily of mutual funds whose fair values are determined by reference to the quoted market price per unit in active markets multiplied by the number of units held without consideration of transaction costs. These assets represent investments held in a consolidated trust to fund the Company's non-qualified deferred compensation plan and are recorded in other long-term assets and other long-term liabilities on our consolidated balance sheets. (2) The Company recognized a contingent consideration liability of $3.6 million in connection with the acquisition of Aquilent in fiscal 2017. As of March 31, 2021, the estimated fair value of the contingent consideration liability was $1.2 million, and was valued using probability-weighted cash flows, which is based on the use of Level 3 fair value measurement inputs. As of March 31, 2022 the relevant statute of limitations pertaining to the contingent liability expired at which point the Company wrote off the existing liability balance. (3) The Company’s interest rate swaps are considered over-the-counter derivatives and fair value is estimated based on the present value of future cash flows using a model-derived valuation that uses Level 2 observable inputs such as interest rate yield curves. See Note 11 to the consolidated financial statements for further discussion on the Company’s derivative instruments designated as cash flow hedges. We did not have any material items that were measured at fair value on a non-recurring basis as of March 31, 2022, with the exception of the assets and liabilities acquired through the acquisitions of Liberty and Tracepoint (see Note 5). The fair value of the Company's cash and cash equivalents, which are Level 1 inputs, approximated its carrying values at March 31, 2022 and 2021. The fair value of the Company's debt instruments approximated its carrying value at March 31, 2022 and 2021. The fair value of debt is determined using quoted prices or other market information obtained from recent trading activity of each debt tranche in markets that are not active (Level 2 inputs). The fair value is corroborated by prices derived from the interest rate spreads of recently completed leveraged loan transactions of a similar credit profile, industry, and terms to that of the Company. The fair value of the Senior Notes due 2029 and Senior Notes due 2028 are determined using quoted prices or other market information obtained from recent trading activity in the high-yield bond market (Level 2 inputs).

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration